Tekla Capital Management LLC has filed its 13F form on August 10, 2023 for Q2 2023 where it was disclosed a total value porftolio of $2.53 Billion distributed in 166 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Amgen Inc with a value of $137M, Johnson & Johnson with a value of $119M, Gilead Sciences, Inc. with a value of $118M, Regeneron Pharmaceuticals, Inc. with a value of $116M, and Vertex Pharmaceuticals Inc with a value of $112M.
Examining the 13F form we can see an decrease of $79.5M in the current position value, from $2.61B to 2.53B.
Below you can find more details about Tekla Capital Management LLC portfolio as well as his latest detailed transactions.
Portfolio value
$2.53 Billion
Healthcare: $2.45 Billion
Real Estate: $50.9 Million
ETFs: $15.4 Million
Basic Materials: $9.44 Million
Stock Holdings Table Market Cap. of $2 Billions to $10 Billions